Furthermore, in our pathway enrichment analyses, Chaga therapy was found to diminish the activity of NKT cells and Tregs within the IL-17 and NF-kappa B signaling pathways, postulating that Chaga may temper T cell-mediated immune functions, thereby mitigating the inflammatory-driven progression of renal fibrosis. This evidence concerns the gene IL17A and renal fibrosis.